Pellino 1 Inhibitors
Pellino 1 is a key regulatory protein involved in the innate immune response and inflammatory signaling pathways. Functionally, Pellino 1 acts as an E3 ubiquitin ligase, catalyzing the attachment of ubiquitin chains to target proteins, thereby modulating their stability, activity, and subcellular localization. In particular, Pellino 1 plays a crucial role in the activation of nuclear factor-kappa B (NF-κB) and mitogen-activated protein kinase (MAPK) signaling pathways in response to various extracellular stimuli, including pathogen-associated molecular patterns (PAMPs) and pro-inflammatory cytokines. Through its interactions with components of the Toll-like receptor (TLR) and interleukin-1 receptor (IL-1R) signaling complexes, Pellino 1 facilitates the ubiquitination and subsequent activation of downstream signaling molecules, leading to the induction of pro-inflammatory gene expression and the initiation of the innate immune response.
Inhibition of Pellino 1 represents a strategy for modulating inflammatory signaling pathways and dampening immune responses in pathological conditions characterized by excessive inflammation. Mechanistically, inhibition of Pellino 1 can be achieved through various approaches, including interference with its enzymatic activity, disruption of protein-protein interactions, or modulation of its expression levels. Small molecule inhibitors targeting the catalytic activity of Pellino 1 hinders its ubiquitin ligase function, thereby inhibiting the ubiquitination and activation of downstream signaling molecules involved in inflammatory responses. Additionally, blocking the interaction between Pellino 1 and its binding partners within the TLR and IL-1R signaling complexes could impede the propagation of inflammatory signals and attenuate the immune response. Understanding the mechanisms underlying Pellino 1 inhibition offers insights into the regulation of inflammatory signaling pathways and provides avenues for intervention in inflammatory diseases.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $62.00 $85.00 $356.00 | 155 | |
BAY 11-7082 is an inhibitor of the NF-κB pathway, acting by preventing the phosphorylation and degradation of IκBα. By inhibiting NF-κB activation, BAY 11-7082 indirectly inhibits Pellino 1, which is a downstream target of NF-κB signaling. The reduction in NF-κB-mediated transcriptional activity leads to decreased Pellino 1 expression and functional inhibition. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is a JNK inhibitor that interferes with the JNK signaling pathway. By inhibiting JNK activation, SP600125 indirectly suppresses Pellino 1, which is regulated by JNK-dependent phosphorylation. The blockade of JNK signaling prevents Pellino 1 activation, highlighting the pivotal role of JNK in modulating Pellino 1 activity in cellular processes. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a phosphoinositide 3-kinase (PI3K) inhibitor that disrupts the PI3K/Akt signaling pathway. By inhibiting PI3K, Wortmannin indirectly hinders the activation of Akt, which is involved in Pellino 1 regulation. The suppression of PI3K/Akt signaling results in the attenuation of Pellino 1 function, illustrating the intricate cross-talk between PI3K/Akt and Pellino 1 pathways. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a p38 MAPK inhibitor that disrupts the p38 MAPK signaling pathway. By inhibiting p38 MAPK, SB203580 indirectly inhibits Pellino 1, which is regulated by p38 MAPK-dependent phosphorylation. The blockade of p38 MAPK signaling leads to decreased Pellino 1 activation, illustrating the critical role of p38 MAPK in modulating Pellino 1 activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that disrupts the PI3K/Akt signaling pathway. Similar to Wortmannin, LY294002 indirectly inhibits Pellino 1 by blocking PI3K, leading to the attenuation of Akt activation. The suppression of PI3K/Akt signaling by LY294002 results in the inhibition of Pellino 1, emphasizing the dependence of Pellino 1 on PI3K/Akt-mediated regulatory pathways. | ||||||
Tyrphostin B42 | 133550-30-8 | sc-3556 | 5 mg | $26.00 | 4 | |
AG-490 is a JAK2 inhibitor that disrupts the JAK/STAT signaling pathway. By inhibiting JAK2, AG-490 indirectly inhibits Pellino 1, which is influenced by JAK/STAT-dependent signaling. The blockade of JAK/STAT signaling leads to decreased Pellino 1 activation, highlighting the intricate regulatory role of JAK/STAT in modulating Pellino 1 activity. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is a MEK inhibitor targeting the MAPK/ERK pathway. Similar to U0126, PD98059 disrupts the MEK/ERK signaling cascade, indirectly inhibiting Pellino 1. Pellino 1 is modulated by ERK-dependent phosphorylation, and the inhibition of this pathway by PD98059 results in decreased Pellino 1 activity, emphasizing the significance of MAPK/ERK signaling in Pellino 1 regulation. | ||||||
SB 202190 | 152121-30-7 | sc-202334 sc-202334A sc-202334B | 1 mg 5 mg 25 mg | $31.00 $128.00 $454.00 | 45 | |
SB202190 is a p38 MAPK inhibitor that disrupts the p38 MAPK signaling pathway. Similar to SB203580, SB202190 indirectly inhibits Pellino 1 by blocking p38 MAPK, which regulates Pellino 1 through phosphorylation. The blockade of p38 MAPK signaling by SB202190 results in decreased Pellino 1 activation, illustrating the critical role of p38 MAPK in modulating Pellino 1 activity. | ||||||
CAL-101 | 870281-82-6 | sc-364453 | 10 mg | $193.00 | 4 | |
CAL-101 (Idelalisib) is a PI3Kδ inhibitor that specifically targets the delta isoform of PI3K. By inhibiting PI3Kδ, Idelalisib disrupts the PI3K/Akt signaling pathway, leading to the indirect inhibition of Pellino 1. The attenuation of PI3K/Akt signaling results in decreased Pellino 1 activation, showcasing the specificity of Idelalisib in modulating the regulatory pathways of Pellino 1. | ||||||
IKK-2 Inhibitor IV | 507475-17-4 | sc-203083 | 500 µg | $133.00 | 12 | |
IKK-2 Inhibitor IV prevents the phosphorylation and degradation of IκBα, indirectly inhibiting Pellino 1. The blockade of NF-κB activation results in decreased Pellino 1 expression and activity, highlighting the regulatory connection between IKK/NF-κB signaling and Pellino 1. | ||||||